3d
News-Medical.Net on MSNScientists link emulsifiers in processed foods to allergy and immune disordersReview identifies common food additives in ultra-processed foods—particularly emulsifiers like carrageenan and polysorbate 80 ...
“The physician shortage that we have long feared. ... is already here” notes AMA President, who also has a masters in Public ...
5d
ZME Science on MSNThis Man Hiccupped Nonstop for Two Years—Until Doctors Found a Clue Hiding in His BloodIf this story sounds extraordinary, it’s not without precedent.
Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils ...
Associated allergic diseases (atopic dermatitis or ... Mixed IgE- & cell-mediated gastrointestinal disorders Eosinophilic esophagitis (EE): symptoms mimicking gastroesophageal reflux but resistant ...
Eosinophilic esophagitis (EoE) presents with a constellation ... to esophageal inflammation in EoE relate to a dysregulated allergic response in the esophageal mucosa. Defects in the epithelial ...
In a video interview with Healio, Benjamin N. Ungar, MD, discussed the risk factors of atopic dermatitis and the comorbidities associated with the condition.
The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...
Press Release: Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD
Dupixent approved as the first-ever biologic medicine in Japan for patients with COPDFollowing recent approvals in the EU, China, and the US, ...
Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results